LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

RNA ligase (ATP)

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
RNA ligase (ATP)
Gene product:
mitochondrial RNA ligase 2
Species:
Leishmania braziliensis
UniProt:
E9AIM1_LEIBR
TriTrypDb:
LbrM.20.5890 , LBRM2903_200074100
Length:
418

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 22
NetGPI no yes: 0, no: 22
Cellular components
Term Name Level Count
GO:0031019 mitochondrial mRNA editing complex 3 1
GO:0032991 protein-containing complex 1 1
GO:0045293 mRNA editing complex 3 1
GO:0098798 mitochondrial protein-containing complex 2 1
GO:1902494 catalytic complex 2 1

Expansion

Sequence features

E9AIM1
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: E9AIM1

Function

Biological processes
Term Name Level Count
GO:0006139 nucleobase-containing compound metabolic process 3 1
GO:0006725 cellular aromatic compound metabolic process 3 1
GO:0006807 nitrogen compound metabolic process 2 1
GO:0008152 metabolic process 1 1
GO:0009451 RNA modification 5 1
GO:0009987 cellular process 1 1
GO:0016070 RNA metabolic process 5 1
GO:0034641 cellular nitrogen compound metabolic process 3 1
GO:0043170 macromolecule metabolic process 3 1
GO:0043412 macromolecule modification 4 1
GO:0044237 cellular metabolic process 2 1
GO:0044238 primary metabolic process 2 1
GO:0046483 heterocycle metabolic process 3 1
GO:0071704 organic substance metabolic process 2 1
GO:0090304 nucleic acid metabolic process 4 1
GO:1901360 organic cyclic compound metabolic process 3 1
Molecular functions
Term Name Level Count
GO:0000166 nucleotide binding 3 23
GO:0003824 catalytic activity 1 23
GO:0003972 RNA ligase (ATP) activity 5 23
GO:0005488 binding 1 23
GO:0005524 ATP binding 5 23
GO:0008452 RNA ligase activity 4 23
GO:0016874 ligase activity 2 23
GO:0016886 ligase activity, forming phosphoric ester bonds 3 23
GO:0017076 purine nucleotide binding 4 23
GO:0030554 adenyl nucleotide binding 5 23
GO:0032553 ribonucleotide binding 3 23
GO:0032555 purine ribonucleotide binding 4 23
GO:0032559 adenyl ribonucleotide binding 5 23
GO:0035639 purine ribonucleoside triphosphate binding 4 23
GO:0036094 small molecule binding 2 23
GO:0043167 ion binding 2 23
GO:0043168 anion binding 3 23
GO:0097159 organic cyclic compound binding 2 23
GO:0097367 carbohydrate derivative binding 2 23
GO:0140098 catalytic activity, acting on RNA 3 23
GO:0140640 catalytic activity, acting on a nucleic acid 2 23
GO:1901265 nucleoside phosphate binding 3 23
GO:1901363 heterocyclic compound binding 2 23

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_NRD_NRD_1 12 14 PF00675 0.511
CLV_NRD_NRD_1 141 143 PF00675 0.331
CLV_NRD_NRD_1 255 257 PF00675 0.390
CLV_NRD_NRD_1 283 285 PF00675 0.539
CLV_NRD_NRD_1 296 298 PF00675 0.389
CLV_NRD_NRD_1 3 5 PF00675 0.538
CLV_NRD_NRD_1 38 40 PF00675 0.426
CLV_NRD_NRD_1 385 387 PF00675 0.369
CLV_NRD_NRD_1 396 398 PF00675 0.357
CLV_PCSK_KEX2_1 12 14 PF00082 0.511
CLV_PCSK_KEX2_1 140 142 PF00082 0.393
CLV_PCSK_KEX2_1 254 256 PF00082 0.323
CLV_PCSK_KEX2_1 283 285 PF00082 0.558
CLV_PCSK_KEX2_1 296 298 PF00082 0.362
CLV_PCSK_KEX2_1 3 5 PF00082 0.538
CLV_PCSK_KEX2_1 38 40 PF00082 0.412
CLV_PCSK_KEX2_1 385 387 PF00082 0.363
CLV_PCSK_KEX2_1 79 81 PF00082 0.293
CLV_PCSK_PC1ET2_1 140 142 PF00082 0.393
CLV_PCSK_PC1ET2_1 79 81 PF00082 0.293
CLV_PCSK_SKI1_1 108 112 PF00082 0.284
CLV_PCSK_SKI1_1 152 156 PF00082 0.425
CLV_PCSK_SKI1_1 22 26 PF00082 0.619
CLV_PCSK_SKI1_1 264 268 PF00082 0.367
CLV_PCSK_SKI1_1 320 324 PF00082 0.342
CLV_PCSK_SKI1_1 363 367 PF00082 0.293
CLV_PCSK_SKI1_1 386 390 PF00082 0.301
CLV_PCSK_SKI1_1 4 8 PF00082 0.680
CLV_PCSK_SKI1_1 405 409 PF00082 0.345
DEG_APCC_DBOX_1 211 219 PF00400 0.388
DEG_APCC_DBOX_1 3 11 PF00400 0.692
DEG_Nend_Nbox_1 1 3 PF02207 0.551
DOC_CDC14_PxL_1 198 206 PF14671 0.197
DOC_CDC14_PxL_1 377 385 PF14671 0.395
DOC_CYCLIN_RxL_1 102 113 PF00134 0.432
DOC_MAPK_gen_1 12 18 PF00069 0.567
DOC_MAPK_gen_1 140 147 PF00069 0.311
DOC_MAPK_gen_1 296 302 PF00069 0.492
DOC_PP1_RVXF_1 388 395 PF00149 0.392
DOC_USP7_MATH_1 78 82 PF00917 0.324
DOC_USP7_MATH_2 346 352 PF00917 0.277
DOC_USP7_UBL2_3 363 367 PF12436 0.292
DOC_WW_Pin1_4 11 16 PF00397 0.496
DOC_WW_Pin1_4 115 120 PF00397 0.388
DOC_WW_Pin1_4 350 355 PF00397 0.311
LIG_14-3-3_CanoR_1 141 146 PF00244 0.216
LIG_14-3-3_CanoR_1 179 186 PF00244 0.277
LIG_14-3-3_CanoR_1 320 327 PF00244 0.422
LIG_14-3-3_CanoR_1 334 339 PF00244 0.332
LIG_AP2alpha_2 345 347 PF02296 0.245
LIG_FHA_1 119 125 PF00498 0.297
LIG_FHA_1 321 327 PF00498 0.411
LIG_FHA_1 387 393 PF00498 0.340
LIG_FHA_1 54 60 PF00498 0.295
LIG_FHA_2 179 185 PF00498 0.411
LIG_FHA_2 188 194 PF00498 0.341
LIG_FHA_2 217 223 PF00498 0.373
LIG_FHA_2 351 357 PF00498 0.321
LIG_LIR_Gen_1 183 194 PF02991 0.286
LIG_LIR_Gen_1 27 35 PF02991 0.388
LIG_LIR_Gen_1 274 282 PF02991 0.457
LIG_LIR_Gen_1 389 399 PF02991 0.278
LIG_LIR_LC3C_4 246 251 PF02991 0.296
LIG_LIR_Nem_3 168 174 PF02991 0.320
LIG_LIR_Nem_3 23 29 PF02991 0.419
LIG_LIR_Nem_3 274 279 PF02991 0.436
LIG_LIR_Nem_3 389 394 PF02991 0.318
LIG_LIR_Nem_3 402 407 PF02991 0.420
LIG_LIR_Nem_3 88 93 PF02991 0.297
LIG_NRBOX 356 362 PF00104 0.283
LIG_Pex14_2 49 53 PF04695 0.311
LIG_PTB_Apo_2 156 163 PF02174 0.382
LIG_SH2_CRK 93 97 PF00017 0.298
LIG_SH2_NCK_1 133 137 PF00017 0.295
LIG_SH2_NCK_1 29 33 PF00017 0.439
LIG_SH2_SRC 133 136 PF00017 0.311
LIG_SH2_SRC 191 194 PF00017 0.266
LIG_SH2_STAP1 172 176 PF00017 0.295
LIG_SH2_STAP1 191 195 PF00017 0.145
LIG_SH2_STAP1 206 210 PF00017 0.145
LIG_SH2_STAT5 165 168 PF00017 0.455
LIG_SH2_STAT5 186 189 PF00017 0.371
LIG_SH2_STAT5 391 394 PF00017 0.341
LIG_SH2_STAT5 399 402 PF00017 0.368
LIG_SH3_1 133 139 PF00018 0.306
LIG_SH3_2 136 141 PF14604 0.432
LIG_SH3_3 133 139 PF00018 0.316
LIG_SH3_3 302 308 PF00018 0.428
LIG_TRAF2_1 181 184 PF00917 0.432
LIG_TRAF2_1 275 278 PF00917 0.420
LIG_UBA3_1 268 272 PF00899 0.326
MOD_CK1_1 117 123 PF00069 0.389
MOD_CK1_1 337 343 PF00069 0.388
MOD_CK2_1 178 184 PF00069 0.334
MOD_CK2_1 187 193 PF00069 0.298
MOD_CK2_1 27 33 PF00069 0.429
MOD_CK2_1 350 356 PF00069 0.432
MOD_GlcNHglycan 18 21 PF01048 0.635
MOD_GlcNHglycan 302 305 PF01048 0.425
MOD_GlcNHglycan 80 83 PF01048 0.301
MOD_GSK3_1 114 121 PF00069 0.192
MOD_GSK3_1 296 303 PF00069 0.449
MOD_GSK3_1 337 344 PF00069 0.295
MOD_GSK3_1 346 353 PF00069 0.295
MOD_N-GLC_1 243 248 PF02516 0.326
MOD_NEK2_1 226 231 PF00069 0.309
MOD_NEK2_1 271 276 PF00069 0.374
MOD_PIKK_1 320 326 PF00454 0.326
MOD_PIKK_1 346 352 PF00454 0.375
MOD_PK_1 141 147 PF00069 0.290
MOD_PK_1 296 302 PF00069 0.410
MOD_PK_1 334 340 PF00069 0.388
MOD_PKA_1 141 147 PF00069 0.326
MOD_PKA_1 296 302 PF00069 0.459
MOD_PKA_2 141 147 PF00069 0.206
MOD_PKA_2 178 184 PF00069 0.324
MOD_PKA_2 27 33 PF00069 0.404
MOD_PKA_2 296 302 PF00069 0.416
MOD_PKB_1 150 158 PF00069 0.277
MOD_Plk_1 355 361 PF00069 0.342
MOD_Plk_1 386 392 PF00069 0.341
MOD_Plk_2-3 27 33 PF00069 0.405
MOD_Plk_4 118 124 PF00069 0.311
MOD_Plk_4 141 147 PF00069 0.197
MOD_Plk_4 264 270 PF00069 0.306
MOD_Plk_4 309 315 PF00069 0.416
MOD_Plk_4 334 340 PF00069 0.388
MOD_Plk_4 356 362 PF00069 0.270
MOD_ProDKin_1 11 17 PF00069 0.488
MOD_ProDKin_1 115 121 PF00069 0.388
MOD_ProDKin_1 350 356 PF00069 0.311
MOD_SUMO_rev_2 258 266 PF00179 0.444
MOD_SUMO_rev_2 368 378 PF00179 0.432
TRG_DiLeu_BaEn_1 356 361 PF01217 0.437
TRG_DiLeu_BaLyEn_6 378 383 PF01217 0.501
TRG_ENDOCYTIC_2 186 189 PF00928 0.280
TRG_ENDOCYTIC_2 29 32 PF00928 0.414
TRG_ENDOCYTIC_2 391 394 PF00928 0.332
TRG_ENDOCYTIC_2 93 96 PF00928 0.266
TRG_ER_diArg_1 11 13 PF00400 0.523
TRG_ER_diArg_1 2 4 PF00400 0.542
TRG_ER_diArg_1 254 256 PF00400 0.353
TRG_ER_diArg_1 295 297 PF00400 0.397
TRG_ER_diArg_1 38 40 PF00400 0.428
TRG_ER_diArg_1 384 386 PF00400 0.455
TRG_NLS_MonoExtN_4 139 144 PF00514 0.452
TRG_Pf-PMV_PEXEL_1 108 113 PF00026 0.341
TRG_Pf-PMV_PEXEL_1 4 9 PF00026 0.410

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1HTX0 Leptomonas seymouri 76% 100%
A0A0N1IKD9 Leptomonas seymouri 41% 81%
A0A0S4IH84 Bodo saltans 40% 85%
A0A0S4JRM1 Bodo saltans 59% 82%
A0A1X0NW43 Trypanosomatidae 68% 100%
A0A1X0P2V9 Trypanosomatidae 42% 90%
A0A3R7NWI2 Trypanosoma rangeli 69% 100%
A0A3S5H791 Leishmania donovani 89% 100%
A0A422NFE4 Trypanosoma rangeli 42% 91%
A0A451EJB4 Leishmania donovani 38% 99%
A4H382 Leishmania braziliensis 39% 100%
A4HRI2 Leishmania infantum 38% 99%
A4HZ02 Leishmania infantum 89% 100%
C9ZIM1 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 67% 100%
C9ZXL1 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 41% 89%
E9AC50 Leishmania major 38% 100%
E9AJE6 Leishmania mexicana (strain MHOM/GT/2001/U1103) 38% 100%
E9AUV4 Leishmania mexicana (strain MHOM/GT/2001/U1103) 90% 100%
P86924 Trypanosoma brucei brucei 67% 100%
P86925 Trypanosoma brucei brucei (strain 927/4 GUTat10.1) 67% 100%
P86926 Trypanosoma brucei brucei 41% 89%
P86927 Trypanosoma brucei brucei (strain 927/4 GUTat10.1) 41% 89%
Q6T452 Leishmania major 88% 100%
V5ASZ3 Trypanosoma cruzi 68% 100%
V5DD75 Trypanosoma cruzi 42% 84%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS